Episode Summary
Executive Summary: The episode explores how Ensemble Capital adjusted its portfolio during COVID-19, emphasizing resilience, balance-sheet strength, and focusing on companies with durable competitive advantages rather than attempting macro timing. Arif Karim also presents a bullish intrinsic-value case for Intuitive Surgical, highlighting its robotic surgery moat, expanding procedure base, and long-term growth runway despite short-term pandemic disruption. The closing discussion argues the stock market’s rebound reflects Fed liquidity, forward-looking expectations, and disconnection from current economic pain.
Main Topics: Portfolio management during COVID-19: Arif explains how the firm monitored China and Italy early, stress-tested holdings, and made tactical portfolio changes to favor more resilient, higher-conviction businesses. Resilience, balance sheets, and capital access: The discussion focuses on evaluating companies by cash flow durability, liquidity, and ability to raise capital during a crisis, with larger firms seen as relatively advantaged. Secular trends are not required to be 'undiscovered': Arif argues investors can still profit from widely known trends like e-commerce and digital payments if they own competitively advantaged companies with long growth runways. Intuitive Surgical investment thesis: Arif outlines why Intuitive Surgical’s robotic surgery platform, consumable model, and global expansion potential made it an attractive long-term holding. Competitive moat and medical technology adoption: The company’s first-mover advantage, surgeon trust, installed base, and training ecosystem are presented as key barriers to entry against rivals like J&J and Medtronic. Why the market can rise amid high unemployment: The final Q&A argues the market is forward-looking and heavily influenced by Fed intervention, liquidity, and lower discount rates rather than current economic data.
Key Arguments: Crisis investing should prioritize companies that can survive a shock to revenues, cash flows, and financing access, not just companies exposed to the strongest macro recovery. The market reaction to COVID-19 was partly anticipated because the team tracked developments in China and Italy early, allowing more resilient positioning. Secular trends do not need to be hidden or newly discovered; well-known trends can still produce outsized returns if the company has durable competitive advantage and long growth duration. Intuitive Surgical is compelling because hospitals make a large upfront investment and then become recurring purchasers of high-margin instruments and services. The company’s moat is built on two decades of technology, surgeon training, trust, installed robots, and procedure know-how, making it hard for later entrants to catch up. COVID-19 hurt Intuitive short term through deferred elective surgeries, but much of that volume should return as a backlog over the next several years. The stock market can reach highs during economic pain because equities are valued on future cash flows and because central-bank liquidity suppresses bond yields and raises relative equity attractiveness. Extreme Fed balance-sheet expansion and near-zero interest rates distort valuation frameworks and support risk assets even when the real economy is weak.
Data Points: Market long-run return: ~9% per year - Used to frame long-term investing and explain expected volatility with strong up and down years. Booking.com stress-test revenue decline: ~70% - Arif said Booking could likely survive even with this magnitude of revenue decline during the pandemic. Global negative-yielding sovereign debt: $10-$12 trillion - Referenced as evidence that capital is abundant and productive uses of capital are scarce. Fed balance sheet pre-crisis: ~$4 trillion - Used as the starting point before emergency stimulus and asset purchases. Fed balance sheet during crisis: ~$7 trillion - Illustrates the scale of monetary expansion in response to COVID-19. Intuitive Surgical procedures in 2012: A couple hundred thousand - Shows the earlier stage of adoption before broader procedure expansion. Intuitive Surgical procedures today: ~1.2 million globally - Demonstrates major growth in procedure volume over time. Intuitive Surgical U.S. procedure mix at the time: ~75% U.S. - Used to highlight future international expansion potential. Intuitive Surgical robots in the field: ~5,600-5,800 - Shows scale of installed base and ecosystem lock-in. Intuitive Surgical annual robot growth: ~10%-12% per year - Illustrates expansion of the installed base. Intuitive Surgical per-procedure instrument revenue: ~$1,800-$1,900 - Recurring revenue from consumables associated with each procedure. Robot sale price: $1 million-$2 million - Upfront system purchase that helps lock in hospitals as recurring customers. Gross margin on instruments: ~80%-90% - Described as highly attractive recurring economics. Gross margin on robot systems: ~60%-70% - Arif’s estimate of the margin profile on the capital equipment itself. Elective surgery decline in China: ~90% reduction in February - COVID impact on procedures in the early phase of the outbreak. China recovery by April call: Down ~20% from pre-COVID levels - Recovery from the initial 90% drop. Global procedure decline at April call: ~65% down - COVID-related impact on Intuitive’s business worldwide. U.S. procedure decline at April call: ~60% down - Regional impact cited during the call. Potential surgical market size: ~300 million surgeries globally - Frames the long-term addressable market for robotic surgery. Public market audience guidance: 1-year TIP financial tool subscription - Prize offered for audience question submission.
Pivotal Quotes: "we only want to own companies where we have a strong sense for their resilience and competitive advantage" — Arif Karim: Explaining portfolio construction during COVID-19 and why resilience matters more than macro timing. "I think the notion of undiscovered or under-appreciated secular trends, while it's very romantic, I don't think it's necessary." — Arif Karim: On secular trend investing and why known trends can still create strong returns. "It looks like a first-generation device from Medtronic and JJ, and by the time they’re out, Intuitive will already have their fifth generation device out in the market." — Arif Karim: Describing Intuitive Surgical’s competitive lead versus emerging rivals.
Implications: Investors should expect continued volatility, policy distortion, and a widening gap between market prices and the real economy. Long-term winners are likely companies with strong moats, recurring revenue, and the ability to reinvest capital productively.
From the Episode
Place for so long. So, I don't think you necessarily need to bet on undiscovered trends or new trends. Of course, you have to understand what the secular trends are because they will be wins at your back or headwinds ahead of you. And you'd prefer a tailwind rather than a headwind. But having said that, I think the most important part of investment analysis from our perspective is being a business analyst and understanding that those companies that are competitively advantaged in the way that they're trying to cap. Capitalize on secular trends? Are they creating value for their customers? Are they creating value for their stakeholders in a way that competitors potentially may not be able to, right? So they can create outsized returns from an ROIC perspective and eventually be able to also, I guess the other part of it is growth duration, right? So to the extent that the secular trend is within a very large market, so call it payments, right, from cash to digital, you can have decades and decades of outsized returns in that kind of a market.
And really spend a bit of time kind of giving me or giving us your opinion as to what do you think is going on with this market that, in my opinion, is schizophrenic. You are surely not alone, Theodore. I think we are all looking at the stock market and the economy and wonder what's going on right now. Now, the first thing to understand is that the stock market is not the economy. It rhymes, but it's not the same thing. So let's first talk about what the economy is. The economy is the sum of all goods and services that Americans in aggregate produce. Before COVID-19, the economy was around $22 trillion annually in the US. And so everything else equal. When you have high unemployment, it won't be good for the economy. For the simple reason that unemployed people don't produce as many goods and services as employed people does. So everything else equal, you're absolutely right.
Style valuations, you're making an underlying assumption. And that underlying assumption is that you're dealing with sound money and you're dealing with a real cost of capital and economic calculation that's occurring in the economy. My argument is today you're not seeing that because all these interest rates are pegged to nothing percent. And if they're pegged to nothing percent, you don't have a cost of capital and you can't do economic calculation for the valuation of things. So this is where I think becoming, or at least having more of a Momentum style of investing in your approach can help significantly because it really takes a lot of the valuation piece out of it and it's just looking at the pure statistics of the price action and it's saying, hey, historically, this volatility is uncharacteristic, therefore it's going up. Or this move based on the price action is uncharacteristic to the downside. Therefore, I need to sell it. And so the calls that our TIP financing.
About We Study Billionaires
We interview and study famous financial billionaires, including Warren Buffett, Ray Dalio, and Howard Marks, and teach you what we learn and how you can apply their investment strategies in the stock market. We Study Billionaires is the largest stock investing podcast show in the world with 180,000,000+ downloads and is hosted by Stig Brodersen, Preston Pysh, William Green, Clay Finck, and Kyle Grieve. This podcast also includes the Richer Wiser Happier series hosted by best-selling author Wi...